S19-517 Three-Recombinase-Dependent Viral Expression for Increased Neuron Specificity Stanford researchers have discovered a method (Triplesect) to express molecular payloads using three-recombinase-dependent viral expression. Karl Deisseroth Charu Ramakrishnan Yoon Seok Kim Lief Fenno
S17-475 Programmed CRISPR-Cas nucleases are potent RNA-guided nickases Researchers at Stanford have shown that two CRISPR-Cas nucleases, Cas9 and Cpf1, can be programmed to produce efficient RNA-guided nickases. Xu Hua Fu Andrew Fire Justin Smith
S19-079 GOTI- method to identify off target mutations caused by gene editors Researchers at Stanford and their colleagues have developed a method to detect off-target mutations caused by gene editing tools. Hui Yang Yixue Li Lars Steinmetz Erwei Zuo Yidi Sun Wu Wei
S15-441 CRISPR/Cas9-mediated Genome Editing to Treat EGFR-mutant Lung Cancer Researchers at Stanford have developed methods of using CRISPR/Cas9-mediated genome editing to treat patients with EGFR-mutant non-small-cell lung cancer (NSCLC). Approximately 85% of lung cancers are NSCLC. Huibin Tang Joseph Shrager